2023
-
Cancer immunologists are gaining new insights into the complexities of immune ecosystems
During a Tuesday morning plenary session, Miriam Merad, MD, PhD, and a panel of cancer immunologists discussed some of the latest discoveries that are driving advances in cancer immunology research and therapeutic development.
-
Researchers working on novel strategies to improve radiation therapy
During a Monday symposium, three researchers, including Quynh-Thu Le, MD, explored the potential of novel strategies to enhance the efficacy of radiation therapy in solid cancer at the individual level, and how these emerging therapies could help clinicians address the challenge of predicting therapeutic response.
-
Promising study results reported in first clinical trials plenary
Researchers reported promising results from five studies, including the first cancer vaccine trial to demonstrate clinical benefit in melanoma, which was reported by Jeffrey S. Weber, MD, PhD, during the first clinical trials plenary session at the Annual Meeting.
-
Trial results suggest new approaches to treat rare cancers
In the second clinical trials plenary session at the Annual Meeting, positive results were reported from four more studies. Timothy A. Yap, MD, PhD, reported on a study that provides the first clinical proof-of-concept for effectively drugging the Hippo-YAP pathway.
-
Schedule highlights from the Program Chair: Tuesday, April 18
Annual Meeting Program Committee Chair Robert H. Vonderheide, MD, DPhil, shares a few highlights from Tuesday’s schedule to help you plan your day.
-
AACR President connects the past and future of cancer research during address
During her presidential address Sunday evening, AACR President Lisa M. Coussens, PhD, FAACR, compared advances in cancer research to her own career journey and shared her hopes for the future of cancer research.
-
Plenary speakers explore the latest advances in the early detection and interception of cancer
Five researchers, including E. Shelley Hwang, MD, MPH, described multiple avenues of research and discovery that demonstrate how cancer can be detected and assessed early to improve patient outcomes.
-
Research advances in childhood cancers are leading to novel therapeutic approaches
Sarah K. Tasian, MD, Jezabel Rodriguez-Blanco, PhD, and Corinne M. Linardic, MD, PhD, discussed advances in pediatric cancer research and therapeutics during a Sunday afternoon symposium.
-
Five more forum sessions on tap Tuesday evening
The last five forum sessions at the Annual Meeting will examine topics including biostatistics in clinical research, engaging diverse communities in clinical trials, and overcoming cancer workforce challenges.
-
Opening Plenary Session showcases important breakthroughs across the spectrum of cancer research
An expert panel of cancer researchers, including Tomi Akinyemiju, PhD, showcased cutting-edge research in diverse fields of study that is opening up new frontiers in all areas of cancer research, from basic science and drug discovery to population science and health equity.